Evidence map›Paper›PMID 42323745›Full record

ArticleWorld journal of urology2026

Outcomes of patients undergoing Optilume

Lea Seiler, Giovanni Lorenzo De Giorgi, Guglielmo Mantica, Leonidas Karapanos, Pascal Viktorin, Yusuf Ahmed, Sarah Clements, Alexander Güdemann, Daniele Jonusaite, Kerem Gerritsen and 5 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lea SeilerDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Giovanni Lorenzo De GiorgiDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Guglielmo ManticaDepartment of Surgical and Diagnostic Integrated Science (DISC), University of Genoa, Genoa, Italy.
Leonidas KarapanosDepartment of Urology, Klinikum Leverkusen, Leverkusen, Germany.
Pascal ViktorinDepartment of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
Yusuf AhmedDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Sarah ClementsDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Alexander GüdemannDepartment of Urology, Kantonsspital Baselland, Liestal, Switzerland.
Daniele JonusaiteDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Kerem GerritsenDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Svetozar SuboticDepartment of Urology, Kantonsspital Baselland, Liestal, Switzerland.
Maciej KwiatkowskiDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Andreas SauerDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Stephen WylerDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Luca AfferiDepartment of Urology, Kantonsspital Aarau, Aarau, Switzerland. luca.afferi@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

objectivesThe Optilume MATERIALS AND

methodsThis retrospective multicenter study included patients treated with Optilume

resultsIn total 86 patients were included across four stricture locations: penile (n = 11, 13%), bulbar/penobulbar (n = 59, 68%), bulbomembranous/membranous (n = 13, 15%) and bladder neck (n = 3, 4%). Postoperative complications within 30 days occurred in 5 (5.8%) patients. Median follow-up duration ranged from 3 to 11 months. Median peak urinary flow increased from 3.5 to 8.8 mL/s preoperatively to 13.5-19 mL/s at 3 months. Stricture-free rates were highest in penile (91%) and bladder neck (100%) strictures, and lower for bulbar (74%) and bulbomembranous/membranous (69%) strictures. On multivariate logistic regression analysis, diabetes was an independent predictor of stricture recurrence (OR = 7.66, 95% CI 1.55-47.12, p = 0.01).

conclusionsOptilume

Indexed as

DilatationPaclitaxelUrethral StrictureAgedCoated Materials, BiocompatibleHumansMaleMiddle AgedRecurrenceRetrospective StudiesTreatment OutcomeCoated Materials, BiocompatiblePaclitaxelBalloon-dilatationOptilumeOutcomesUrethral stricture

Identifiers

PMID42323745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.